A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791

NCT02370043 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers
Insulin Resistance

Interventions

DRUG: KQ-791
DRUG: KQ-791 (after meal)
DRUG: Placebo

Sponsor

Kaneq Bioscience Limited